Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Respiratory Medicine

Journal Scan / Research · May 01, 2023

Effect of the Antifibrotic Drug Nintedanib on Macrophage Phenotypes

American Journal of Respiratory Cell and Molecular Biology

 

Additional Info

American Journal of Respiratory Cell and Molecular Biology
Antifibrotic Drug Nintedanib Inhibits CSF1R to Promote IL-4-associated Tissue Repair Macrophages
Am. J. Respir. Cell Mol. Biol. 2023 Apr 01;68(4)366-380, CK Watson, D Schloesser, K Fundel-Clemens, C Lerner, S Gabler, P Baskaran, CT Wohnhaas, S Dichtl, HJ Huber, K Ask, F Gantner, C Viollet, MJ Thomas, F Ramirez, PJ Murray, KC El Kasmi

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading